Government Funding of Medical Innovations: High Tech or Low Tech?
What drives the costs of healthcare in the United States? Every year sees new and exciting innovations to treat rare diseases, but these innovations are also very costly. Many low tech medical devices or interventions can still be used to improve the health of the majority of the population. Although many of these things are proven and easily available, many communities lack consistent access to them. How do we intelligently allocate spending between specialized high tech tools and low tech devices?
Dr. Henry I. Miller is a Senior Fellow in Health Studies at the Pacific Research Institute, and the former founding Director of the FDA Office of Biotechnology.
The Federalist Society and Regulatory Transparency Project take no position on particular legal or public policy matters. All expressions of opinion are those of the speaker(s). To join the debate, please email us at [email protected].
